Long-Acting Injectable Cabotegravir and Rilpivirine in a Pregnant Woman With HIV
Clinical Infectious Diseases · 17.12.2024 · 79 (6) · 1468-1471
DOI: 10.1093/cid/ciae242 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Infectious Diseases, online erschienen am 03.05.2024. Verfasst von Lena van der Wekken-Pas und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Radboud University Medical Center, Radboud Institute for Medical Innovations (RIMI), Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: HIV Infections, Pyridones, Rilpivirine, Pregnancy Complications, Infectious. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
This case report describes the effects of bimonthly long-acting injectable cabotegravir (CAB)/RPV before and throughout pregnancy. CAB concentrations were comparable to those in nonpregnant individuals; RPV concentrations were 70%–75% lower. No virologic failure or vertical transmission occurred. Despite placental transfer, no congenital malformations were noted. Bimonthly long-acting injectable CAB/RPV may not be suitable for pregnant women, and monitoring of exposed infants is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Radboud University Medical Center, Radboud Institute for Medical Innovations (RIMI), Nijmegen, The Netherlands.
- Department of Obstetrics and Gynecology, LMU University Hospital, Munich, Germany.
- Department of Internal Medicine, MVZ München am Goetheplatz, Munich, Germany.
- Department of Gynecology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
ORCID-Profile: Lena van der Wekken-Pas
Zitieren
APA
van der Wekken-Pas, L., Weiss, F., Simon-Zuber, C., Sebisch, R., Wiese, C., van Leeuwen, E., Burger, D., & Colbers, A. (2024). Long-Acting Injectable Cabotegravir and Rilpivirine in a Pregnant Woman With HIV. Clinical Infectious Diseases, 79(6), 1468-1471. https://doi.org/10.1093/cid/ciae242
Vancouver
van der Wekken-Pas L, Weiss F, Simon-Zuber C, Sebisch R, Wiese C, van Leeuwen E, et al. Long-Acting Injectable Cabotegravir and Rilpivirine in a Pregnant Woman With HIV. Clinical Infectious Diseases. 2024;79(6):1468-1471. doi:10.1093/cid/ciae242
BibTeX
@article{vanderWekkenPas2024,
author = {van der Wekken-Pas, Lena and Weiss, Fabian and Simon-Zuber, Charlotte and Sebisch, Rena and Wiese, Carmen and van Leeuwen, Elisabeth and Burger, David and Colbers, Angela},
title = {Long-Acting Injectable Cabotegravir and Rilpivirine in a Pregnant Woman With HIV},
journal = {Clinical Infectious Diseases},
year = {2024},
volume = {79},
number = {6},
pages = {1468--1471},
doi = {10.1093/cid/ciae242}
}
EUVIMED